PDF Publication Title:
Text from PDF Page: 010
Nagaya et al. Published OnlineFirst June 6, 2017; DOI: 10.1158/1541-7786.MCR-17-0164 men with prostate cancer recurrence following radical prostatectomy. Cancer Biother Radiopharm 1999;14:99–111. 35. Sato K, Sato N, Xu B, Nakamura Y, Nagaya T, Choyke PL, et al. Spatially selective depletion of tumor-associated regulatory T cells with near-infra- red photoimmunotherapy. Sci Transl Med 2016;8:352ra110. 36. Kobayashi H, Watanabe R, Choyke PL. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics 2013;4:81–9. 37. Sano K, Nakajima T, Choyke PL, Kobayashi H. Markedly enhanced per- meability and retention effects induced by photo-immunotherapy of tumors. ACS Nano 2013;7:717–24. 38. Sano K, Nakajima T, Choyke PL, Kobayashi H. The effect of photoimmu- notherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapy. Mol Cancer Ther 2014;13:426–32. 39. Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Kobayashi H. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT). J Control Release 2016;232:1–8. 40. Mitsunaga M, Nakajima T, Sano K, Choyke PL, Kobayashi H. Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. Bioconjug Chem 2012; 23:604–9. 41. Nagaya T, Sato K, Harada T, Nakamura Y, Choyke PL, Kobayashi H. Near infrared photoimmunotherapy targeting EGFR positive triple negative breast cancer: optimizing the conjugate-light regimen. PLoS One 2015; 10:e0136829. 42. Hambley TW, Hait WN. Is anticancer drug development heading in the right direction? Cancer Res 2009;69:1259–62. 43. Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer 2006;6:583–92. 44. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893–5. 45. Nowell PC. Mechanisms of tumor progression. Cancer Res 1986;46: 2203–7. 46. Kerr JF. Shrinkage necrosis: a distinct mode of cellular death. J Pathol 1971;105:13–20. 47. Willingham MC. Cytochemical methods for the detection of apoptosis. J Histochem Cytochem 1999;47:1101–10. 48. Ziegler U, Groscurth P. Morphological features of cell death. News Physiol Sci 2004;19:124–8. 49. Hiroshima Y, Maawy A, Zhang Y, Sato S, Murakami T, Yamamoto M, et al. Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models. PLoS One 2014;9:e99977. 50. Pass HI, Temeck BK, Kranda K, Thomas G, Russo A, Smith P, et al. Phase III randomized trial of surgery with or without intraopera- tive photodynamic therapy and postoperative immunochemo- therapy for malignant pleural mesothelioma. Ann Surg Oncol 1997; 4:628–33. 1162 Mol Cancer Res; 15(9) September 2017 Molecular Cancer Research Downloaded from mcr.aacrjournals.org on December 1, 2020. © 2017 American Association for Cancer Research.PDF Image | Near-Infrared Photoimmunotherapy Targeting Prostate Cancer
PDF Search Title:
Near-Infrared Photoimmunotherapy Targeting Prostate CancerOriginal File Name Searched:
near-ir-photoimmunotherapy-prostate-cancer.pdfDIY PDF Search: Google It | Yahoo | Bing
Cruise Ship Reviews | Luxury Resort | Jet | Yacht | and Travel Tech More Info
Cruising Review Topics and Articles More Info
Software based on Filemaker for the travel industry More Info
The Burgenstock Resort: Reviews on CruisingReview website... More Info
Resort Reviews: World Class resorts... More Info
The Riffelalp Resort: Reviews on CruisingReview website... More Info
CONTACT TEL: 608-238-6001 Email: greg@cruisingreview.com (Standard Web Page)